AMGEN INC reported revenue of $10.05B for the period ended 2026-06-30, +9.5% year on year. Net income was $2.38B, a 23.6% net margin on a 72.0% gross margin. The largest revenue line is Product at 95% of the total. Free cash flow for the period was $3.49B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $10.05B | +9.5% |
| Gross profit | $7.24B | — |
| Operating income | $3.51B | — |
| Net income | $2.38B | +65.9% |
| Gross margin | 72.0% | Net margin 23.6% |
| Revenue Q/Q | +16.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| Product | $9.54B | 94.9% |
| Product And Service Other | $0.52B | 5.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.81B | 28.0% |
| SG&A | $1.75B | 17.4% |
| Tax & other | $1.14B | 11.3% |
| Item | Amount |
|---|---|
| Total assets | $95.64B |
| Total liabilities | $83.95B |
| Shareholders' equity | $11.69B |
| Equity / assets | 12.2% |
| Operating cash flow | $4.00B |
| Capital expenditure | $0.51B |
| Free cash flow | $3.49B |
| Cash conversion (OCF / net income) | 169% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
APH ・ ADI ・ AON ・ APA ・ APO ・ AAPL ・ AMAT ・ APP ・ APTV ・ ACGL ・ ADM ・ ARES
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies